Last reviewed · How we verify

NCT06381232

Collection and Analyses of Physiological, Physical, and Molecular Data From a Diverse Population

Recruiting now Last updated 24 April 2024
What this trial tests

trial testing No Intervention in General Health in 20,000 participants. Currently enrolling.

Timeline
23 July 2018
Primary endpoint
23 July 2028
23 July 2028

Quick facts

Lead sponsorViome
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment20,000
Start date23 July 2018
Primary completion23 July 2028
Estimated completion23 July 2028
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Viome

Who can join

Eligibility, any sex, with General Health or Wellness. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the study is to collect and analyze physiological, physical, and molecular data from a diverse population to increase our understanding of how such parameters are associated with health and disease.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. The Human Gut Microbiome Activity Is Resilient and Stable for up to Six Months: A Large Stool Metatranscriptomic Study.
    Toma R, Hu L, Shen N, Patridge E, et al · · 2026 · PMID 42075232 · DOI 10.3390/microorganisms14040835

Verify or expand the search:

Other trials of No Intervention

Trials testing the same drug.

Other recruiting trials for General Health

Currently open trials in the same condition.

Other Viome trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06381232.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing